A Phase I trial exploring the gene therapy in patients with alpha-1 antitrypsin ...
The European Commission has approved Enrylaze for treating acute lymphoblastic l...
The WHO and the World Bank have published the 2023 UHC Global Monitoring Report,...
According to GlobalData, the number of individuals affected by rheumatoid arthri...
JURA Bio has entered into a research collaboration with Replay cell therapy prod...
The UK-based surgical robotics company has now raised over $1bn in funding, ceme...
The US Department of Defense grant is to study methylone for the rapid and long-...
Novo Holdings has acquired Paratek Pharmaceuticals for nearly $462m to bolster i...
Pfizer’s shot to protect infants against respiratory syncytial virus by vaccinat...
"We know that many Americans don't have $500 in savings, [yet] many Americans ha...
For only the second time in history, surgeons transplanted a heart from a geneti...
Yale and one of its professors agreed to settle allegations that they wrongly wi...
A drug from AstraZeneca tamped down the progression of breast cancer, after the ...
Markey and Manchin: “Other studies have already evaluated prolonged opioid use w...
In North Carolina, a pilot program aims to comprehensively test and evaluate how...
Far too few people know about 988, the new mental health emergency hotline. Smar...
